MetALD Conference (@metaldconf) 's Twitter Profile
MetALD Conference

@metaldconf

San Diego MetALD Conference: Opportunities and Challenges in Biomarkers and Clinical Drug Development

ID: 1841907288698687488

linkhttps://www.metaldconference.org/ calendar_today03-10-2024 18:25:40

23 Tweet

45 Followers

5 Following

MetALD Conference (@metaldconf) 's Twitter Profile Photo

Ramon Bataller, MD, PHD Ramon Bataller is discussing current and emerging therapies for MetALD at the San Diego MetALD Conference! Register now to hear his insights at loom.ly/dbXQxmA.

Ramon Bataller, MD, PHD <a href="/rabataller/">Ramon Bataller</a> is discussing current and emerging therapies for MetALD at the San Diego MetALD Conference! Register now to hear his insights at loom.ly/dbXQxmA.
MetALD Conference (@metaldconf) 's Twitter Profile Photo

Dr. Vijay H. Shah is teaching you how to incorporate PEth and other biomarkers in clinical trials, studies and routine clinical practice. Join him at MetALD Conference on November 14th. Register at loom.ly/dbXQxmA. Vijay Shah

Dr. Vijay H. Shah is teaching you how to incorporate PEth and other biomarkers in clinical trials, studies and routine clinical practice. Join him at MetALD Conference on November 14th. Register at loom.ly/dbXQxmA. <a href="/Dr_Vijay_Shah/">Vijay Shah</a>
MetALD Conference (@metaldconf) 's Twitter Profile Photo

Global Epidemiology of Alcohol Use and Metabolic Dysfunction in Liver Disease is being presented by Aleksander Krag at MetALD Conference! Don't miss this insightful session- Register now at loom.ly/Vr0YS88 Aleksander Krag

Global Epidemiology of Alcohol Use and Metabolic Dysfunction in Liver Disease is being presented by Aleksander Krag at MetALD Conference! Don't miss this insightful session- Register now at loom.ly/Vr0YS88 <a href="/AleksanderKrag/">Aleksander Krag</a>
MetALD Conference (@metaldconf) 's Twitter Profile Photo

Juan Pablo Arab, MD, FRCPC is discussing Risk Factors for MetALD, Natural History, and Risk of Progression to Cirrhosis and HE Mortality/Transplant at MetALD Conference! Juan Pablo (JP) Arab, MD 

Juan Pablo Arab, MD, FRCPC is discussing Risk Factors for MetALD, Natural History, and Risk of Progression to Cirrhosis and HE Mortality/Transplant at MetALD Conference! <a href="/juanpabloarab/">Juan Pablo (JP) Arab, MD </a>
MetALD Conference (@metaldconf) 's Twitter Profile Photo

Mack Mitchell, MD is answering your pressing questions about MetALD at the MetALD Conference in San Diego! Learn how to access and treat alcohol use in MetALD and how to consider alcohol use in clinical trials. Register now at loom.ly/dbXQxmA!

Mack Mitchell, MD is answering your pressing questions about MetALD at the MetALD Conference in San Diego! Learn how to access and treat alcohol use in MetALD and how to consider alcohol use in clinical trials. Register now at loom.ly/dbXQxmA!
Altimmune, Inc. (@altimmuneinc) 's Twitter Profile Photo

We’re proud to sponsor this year’s MetALD Conference exploring the opportunities & challenges in #clinical drug development as we continue to advance innovative therapeutics for patients with #metabolic dysfunction-associated liver diseases: bit.ly/3CboUsn